BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7139526)

  • 1. Post-therapeutic acute malignant myeloproliferative syndrome and acute nonlymphocytic leukemia in non-Hodgkin's lymphoma.
    Gomez GA; Aggarwal KK; Han T
    Cancer; 1982 Dec; 50(11):2285-8. PubMed ID: 7139526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence of acute nonlymphocytic leukemia in a prospective randomized study of treatment for Hodgkin's disease.
    Gomez GA; Friedman M; Reese P
    Am J Clin Oncol; 1983 Jun; 6(3):319-23. PubMed ID: 6342359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute nonlymphocytic leukemia and acute myeloproliferative syndrome following radiation therapy for non-Hodgkin's lymphoma and chronic lymphocytic leukemia: clinical studies.
    O'Donnell JF; Brereton HD; Greco FA; Gralnick HR; Johnson RE
    Cancer; 1979 Nov; 44(5):1930-8. PubMed ID: 498058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second neoplasms in patients with Hodgkin's disease following combined modality therapy--the Yale experience.
    Koletsky AJ; Bertino JR; Farber LR; Prosnitz LR; Kapp DS; Fischer D; Portlock CS
    J Clin Oncol; 1986 Mar; 4(3):311-7. PubMed ID: 3950674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of a treatment dose response in acute nonlymphocytic leukemias which occur after therapy of non-Hodgkin's lymphoma.
    Greene MH; Young RC; Merrill JM; DeVita VT
    Cancer Res; 1983 Apr; 43(4):1891-8. PubMed ID: 6572558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute non-lymphocytic leukemia and acute myeloproliferative syndrome following radiation therapy for non-Hodgkin's lymphoma and chronic lymphocytic leukemia: cytogenetic studies.
    Whang-Peng J; Knutsen T; O'Donnell JF; Brereton HD
    Cancer; 1979 Nov; 44(5):1592-600. PubMed ID: 498031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of leukemia following treatment for non-Hodgkin's lymphoma.
    Travis LB; Curtis RE; Stovall M; Holowaty EJ; van Leeuwen FE; Glimelius B; Lynch CF; Hagenbeek A; Li CY; Banks PM
    J Natl Cancer Inst; 1994 Oct; 86(19):1450-7. PubMed ID: 8089863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fifteen-year experience in Hodgkin's disease: role of combined modality treatment and splenectomy in the incidence of secondary acute leukemia.
    Zinzani PL; Fiacchini M; Mazza P; Gherlinzoni F; Bocchia M; Tura S
    Haematologica; 1991; 76(4):305-10. PubMed ID: 1724437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Second neoplasms as a late complication of the treatment of Hodgkin's disease].
    Morales MD; González FA; Villegas A; del Potro E; Díaz Mediavilla J; Martínez R; Alvarez A; Colomé JA
    Sangre (Barc); 1992 Dec; 37(6):429-33. PubMed ID: 1293793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Secondary neoplasms in patients treated by chemotherapy and/or radiotherapy].
    Rytlewska M; Borkowski W
    Wiad Lek; 1983 Feb; 36(4):311-5. PubMed ID: 6344440
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute nonlymphocytic leukemia: a delayed complication of Hodgkin's disease therapy: analysis of 109 cases.
    Cadman EC; Capizzi RL; Bertino JR
    Cancer; 1977 Sep; 40(3):1280-96. PubMed ID: 409479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second neoplasms in Hodgkin's disease: current controversies.
    Zarrabi MH; Rosner F
    Hematol Oncol Clin North Am; 1989 Jun; 3(2):303-18. PubMed ID: 2663829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agents.
    Pedersen-Bjergaard J; Ersbøll J; Sørensen HM; Keiding N; Larsen SO; Philip P; Larsen MS; Schultz H; Nissen NI
    Ann Intern Med; 1985 Aug; 103(2):195-200. PubMed ID: 4014901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second malignancies in Hodgkin's disease: a complication of certain forms of treatment.
    Valagussa P; Santoro A; Kenda R; Fossati Bellani F; Franchi F; Banfi A; Rilke F; Bonadonna G
    Br Med J; 1980 Jan; 280(6209):216-9. PubMed ID: 6775732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute myelogenous leukemia as a late complication of the multimodality therapy for Hodgkin's disease.
    Trump DL; Cowall DE
    Johns Hopkins Med J; 1977 Nov; 141(5):249-51. PubMed ID: 270597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute leukemia in patients treated for Hodgkin's disease].
    Boccaccio P; Rosa F; Casciaro S; D'Elia P; Romagnoli M; Ghio R
    Recenti Prog Med; 1988 Jan; 79(1):32-7. PubMed ID: 3375542
    [No Abstract]   [Full Text] [Related]  

  • 18. Second acute leukemia and other malignancies following treatment for Hodgkin's disease.
    Valagussa P; Santoro A; Fossati-Bellani F; Banfi A; Bonadonna G
    J Clin Oncol; 1986 Jun; 4(6):830-7. PubMed ID: 3711960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukemia following low-dose total body irradiation and chemotherapy for non-Hodgkin's lymphoma.
    Travis LB; Weeks J; Curtis RE; Chaffey JT; Stovall M; Banks PM; Boice JD
    J Clin Oncol; 1996 Feb; 14(2):565-71. PubMed ID: 8636772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second cancers following antineoplastic therapy.
    Dorr FA; Coltman CA
    Curr Probl Cancer; 1985 Feb; 9(2):1-43. PubMed ID: 3888536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.